Young-Lan Kwak

Dr. Young-Lan Kwak

Department of Anesthesiology and Pain Medicine, Yonsei University, Seoul, Korea
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Kidney International
Verified
Journal Article
Closed access
PDF file
JCJin Sun Cho
Jin Sun Cho
JSJae-Kwang Shim
Jae-Kwang Shim
Sarah SohSarah Soh
Sarah Soh
MKMin Kyung Kim
Min Kyung Kim
YKYoung-Lan Kwak
Young-Lan Kwak

18 January 2002 in Anaesthesia
Verified
Journal Article
Open access
PDF file
YKYoung-Lan Kwak
Young-Lan Kwak
CLC. S. Lee
C. S. Lee
YPY. H. Park
Y. H. Park
YHY. W. Hong
Y. W. Hong
In this study the effect of phenylephrine and norepinephrine for the treatment of systemic hypotension were evaluated in patients with chronic pulmonary hypertension. When systemic hypotension (systolic arterial pressure < 100 mmHg) occurred following induction of anaesthesia, either phenylephrine or norepinephrine were infused in a random manner to raise the systolic blood pressure by 30% and 50% above baseline values. Norepinephrine decreased the ratio of pulmonary arterial pressure to systemic blood pressure without a change in cardiac index. However, phenylephrine did not increase arterial blood pressure by more than 30% from baseline in one‐third of patients and decreased cardiac index without a significant decrease in ratio of pulmonary arterial pressure to systemic blood pressure. These vasoconstrictors showed different systemic and pulmonary haemodynamic effects in patients with chronic pulmonary hypertension as compared to acute pulmonary hypertension. Norepinephrine was considered to be preferable to phenylephrine for the treatment of hypotension in patients with chronic pulmonary hypertension.

1 July 2011 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
YCYong Seon Choi
Yong Seon Choi
JSJae-Kwang Shim
Jae-Kwang Shim
JKJong Chan Kim
Jong Chan Kim
KKKyu-Sik Kang
Kyu-Sik Kang
YSYong Han Seo
Yong Han Seo
YKYoung-Lan Kwak
Young-Lan Kwak

1 December 2010 in JACC
Verified
Journal Article
Closed access
YKYoung-Lan Kwak
Young-Lan Kwak
JKJong-Chan Kim
Jong-Chan Kim
YCYong Seon Choi
Yong Seon Choi
KYKyung-Jong Yoo
Kyung-Jong Yoo
YSYoung Song
Young Song
JSJae-Kwang Shim
Jae-Kwang Shim

1 August 2014 in Kidney International
Verified
Journal Article
Closed access
YYYoungchul Yoo
Youngchul Yoo
JSJae-Kwang Shim
Jae-Kwang Shim
YSYoung Song
Young Song
SYSo-Young Yang
So-Young Yang
YKYoung-Lan Kwak
Young-Lan Kwak

1 March 2011 in Spine
Verified
Journal Article
Closed access
JKJong Chan Kim
Jong Chan Kim
YCYong Seon Choi
Yong Seon Choi
KKKeung Nyun Kim
Keung Nyun Kim
JSJae-Kwang Shim
Jae-Kwang Shim
JLJi Yeon Lee
Ji Yeon Lee
YKYoung-Lan Kwak
Young-Lan Kwak
A prospective, randomized, controlled, and double-blind trial. To evaluate the effects of 2 different doses of perioperative pregabalin administration, twice on the day of surgery, on acute postoperative pain after spinal surgery. Besides its well-established role on neuropathic pain, pregabalin seems to be a promising adjunct to multimodal analgesic regimen following surgery. No comprehensive data exist regarding the optimal dosage of pregabalin on reducing postoperative pain and opioid consumption in spinal surgery. Patients were randomly assigned to 1 of 3 groups. The placebo group (n = 28) received placebo capsules 1 hour before the anesthetic induction and 12 hours after surgery. The pregabalin groups received pregabalin 75 mg (P75 group, n = 28) or 150 mg (P150 group, n = 28), respectively at the same points. Assessed variables were total amount of administered fentanyl-based intravenous patient-controlled analgesia, pain intensity, and the frequency of rescue analgesic administered during the first 48 hours after surgery, subdivided into the following 4 periods: on arrival of patient to the postanesthesia care unit, 1 to 6 hours, 6 to 24 hours, and 24 to 48 hours. RESULTS.: The amount of patient-controlled analgesia volume infused until 24 hours (P 5 0.025) and 48 hours (P 5 0.028) after surgery was significantly less in the P150 group compared with the control group. The frequency of additional anodynes administered until 6 hours (P 5 0.049) and 24 hours (P 5 0.045) after surgery was significantly less in the P150 group compared with the control group. Perioperative administration of pregabalin 150 mg before and 12 hours after surgery, but not 75 mg, significantly reduced opioid consumption and the use of additional pain rescue for 48 hours after surgery without significant side effects in patients undergoing spinal fusion surgery.